Healthcare DIVE July 24, 2024
Susanna Vogel and Rebecca Pifer

Top executives of CVS Caremark, Optum Rx and Express Scripts made a rare congressional appearance to defend pharmacy benefit managers’ drug pricing policies.

In a House Committee on Oversight and Accountability hearing Tuesday, representatives from across the aisle pressed executives from the largest pharmacy benefit managers in the nation — CVS Caremark, UnitedHealth Group’s Optum Rx and Cigna’s Express Scripts — on their role in rising prescription drug costs.

While congressional hearings on PBMs have ticked up in frequency, it is rare for lawmakers to hear directly from top decision-makers at the companies. The last time was in 2019, when a different group of executives appeared before the Senate Finance Committee.

That changed yesterday when Adam Kautzner, president of Express...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards
The Evolving Role of Pharmacists in Custom Pathway Implementation
Pharma Pulse 11/25/24: Deepening Patient Relationships,

Share This Article